Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives of this study are: • To determine the antiviral efficacy of combination treatment with sofosbuvir/GS-5885 fixed-dose combination ± RBV as measured by the proportion of subjects with SVR 12 weeks after discontinuation of therapy (SVR12). • To evaluate the safety and tolerability of each treatment regimen as assessed by review of the accumulated safety data
Inclusion criteria
- Chronic Genotype 1 Hepatitis C Virus Infection